Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | LPO | P22079 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MLYCD | O95822 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12087626 | 0.91 | TSHR (0.43) | TSHRFDPSCXCR4MEN1KMT2A | |
| SCHEMBL28993653 | 0.85 | TSHR (0.40) | TSHRFDPSCXCR4MEN1KMT2A | |
| SCHEMBL16213758 | 0.84 | LMNA (0.51) | TSHRFDPSCXCR4MEN1KMT2A | |
| SCHEMBL8264017 | 0.84 | TSHR (0.44) | TSHRFDPSCXCR4MEN1KMT2A | |
| SCHEMBL13210024 | 0.83 | TSHR (0.42) | TSHRFDPSCXCR4MEN1KMT2A | |
| SCHEMBL12087470 | 0.83 | CXCR4 (0.46) | TSHRFDPSCXCR4MEN1KMT2A | |
| SCHEMBL12087478 | 0.83 | CYP3A4 (0.39) | TSHRFDPSCXCR4MEN1KMT2A | |
| SCHEMBL13785302 | 0.83 | CXCR4 (0.64) | TSHRFDPSCXCR4MEN1KMT2A | |
| SCHEMBL1628456 | 0.83 | MAPT (0.54) | TSHRCXCR4MEN1KMT2ALMNA | |
| SCHEMBL1627995 | 0.83 | MAPT (0.54) | TSHRCXCR4MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8951695-B2 | Redox fuel cell with catholyte redox mediator | ACAL ENERGY LIMITED (GB) | 2015-02-10 | — | — | US | disclosed |
| US-8951695-B2 | Redox fuel cell with catholyte redox mediator | ACAL ENERGY LIMITED (GB) | 2015-02-10 | — | — | US | disclosed |
| EP-2238641-B1 | REDOX FUEL CELLS | ACAL ENERGY LTD (GB) | 2012-09-05 | — | — | EP | disclosed |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-8048982-B2 | Method for producing aromatic compound polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20110091746-A1 | FUEL CELLS | ACAL ENERGY LIMITED (GB) | 2011-04-21 | — | — | US | disclosed |
| US-20110091746-A1 | FUEL CELLS | ACAL ENERGY LIMITED (GB) | 2011-04-21 | — | — | US | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009093080-A1 | FUEL CELLS | ACAL ENERGY LIMITED (GB) | 2009-07-30 | — | — | WO | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
| EP-1114836-B1 | PROCESS FOR PRODUCING A RESIN COMPOSITION | NAT INST OF ADVANCED IND SCIEN (JP) | 2006-11-08 | — | — | EP | disclosed |
| US-6344516-B1 | TRANSITION METAL COMPLEX CATALYST, OXIDATATIVE POLYMERIZATION OF PHENOL-CONTAINING VEGETABLE OIL | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2002-02-05 | — | — | US | disclosed |
| EP-1114836-A1 | RESIN COMPOSITION AND PROCESS FOR PRODUCING THE SAME | Japan as represented by Secretary of Agency of Industrial Science and Technology (JP) | 2001-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | TSHR 3657/4885FDPS 875/4885CXCR4 2980/4885 |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | PAH, MAOA, AHR | TSHR 3727/4885FDPS 876/4885CXCR4 3016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.